181.
Efficacy and safety of ezetimibe coadministered with lovastatin in primary hypercholesterolemia
by Kerzner, Boris
The American journal of cardiology, 2003, Vol.91 (4), p.418-424
182.
Safety and Efficacy of Ezetimibe Added to Atorvastatin Versus Up Titration of Atorvastatin to 40 mg in Patients ≥65 Years of Age (from the ZETia in the ELDerly [ZETELD] Study)
by Zieve, Franklin, MD, PhD
The American journal of cardiology, 2010, Vol.105 (5), p.656-663
183.
Tendon Rupture Associated With Simvastatin/Ezetimibe Therapy
by Pullatt, Raja C., MD
The American journal of cardiology, 2007, Vol.100 (1), p.152-153
184.
Effectiveness of Ezetimibe Alone or in Combination With Twice a Week Atorvastatin (10 mg) for Statin Intolerant High-Risk Patients
by Athyros, Vasilios G., MD
The American journal of cardiology, 2008, Vol.101 (4), p.483-485
185.
Efficacy of Rosuvastatin (5 mg and 10 mg) Twice a Week in Patients Intolerant to Daily Statins
by Gadarla, Mamatha, MD
The American journal of cardiology, 2008, Vol.101 (12), p.1747-1748
186.
Effect of coadministration of ezetimibe and simvastatin on high-sensitivity C-reactive protein
by Sager, Philip T
The American journal of cardiology, 2003, Vol.92 (12), p.1414-1418
187.
Pleiotropic Effects and Cholesterol-Lowering Therapy
by Shaw, Steven M
Cardiology, 2008, Vol.112 (1), p.4-12
188.
Long-term (48-week) safety of ezetimibe 10 mg/day coadministered with simvastatin compared to simvastatin alone in patients with primary hypercholesterolemia
by Bays, Harold
Current medical research and opinion, 2008, Vol.24 (10), p.2953-2966
189.
Two spectrophotometric methods for simultaneous determination of some antihyperlipidemic drugs
by Abdelwahab, Nada S
Journal of pharmaceutical analysis, 2012, Vol.2 (4), p.279-284
190.
Effect of Obesity on Left Ventricular Mass and Systolic Function in Patients With Asymptomatic Aortic Stenosis (a Simvastatin Ezetimibe in Aortic Stenosis [SEAS] Substudy)
by Lund, Barbara P., MD
The American journal of cardiology, 2010, Vol.105 (10), p.1456-1460
191.
Impact of Hypertriglyceridemia on Endothelial Dysfunction During Statin ± Ezetimibe Therapy in Patients With Coronary Heart Disease
by Yunoki, Kei, MD
The American journal of cardiology, 2011, Vol.108 (3), p.333-339
192.
Efficacy and Safety of Coadministration of Rosuvastatin , Ezetimibe , and Colestimide in Heterozygous Familial Hypercholesterolemia
by Kawashiri, Masa-aki, MD
The American journal of cardiology, 2012, Vol.109 (3), p.364-369
193.
Lipid-lowering therapy and mortality post-MI: is it just about the LDL?
by Halcox, Julian P
Heart (British Cardiac Society), 2014, Vol.100 (11), p.825-826
194.
Effect of anti-hyperlipidemia drugs on the alpha-tocopherol concentration and their potential for murine malaria infection
by Kume, Aiko
Parasitology research (1987), 2015, Vol.115 (1), p.69-75
195.
Comparison of Effects of Ezetimibe/Simvastatin Versus Simvastatin Versus Atorvastatin in Reducing C-Reactive Protein and Low-Density Lipoprotein Cholesterol Levels
by Pearson, Thomas, MD, PhD
The American journal of cardiology, 2007, Vol.99 (12), p.1706-1713.e1
196.
New medications which decrease levothyroxine absorption
by John-Kalarickal, Jennifer
Thyroid (New York, N.Y.), 2007, Vol.17 (8), p.763-765
197.
Usefulness of the Electrocardiogram in Predicting Cardiovascular Mortality in Asymptomatic Adults With Aortic Stenosis (from the Simvastatin and Ezetimibe in Aortic Stenosis Study)
by Greve, Anders M., MD, PhD
The American journal of cardiology, 2014, Vol.114 (5), p.751-756
198.
Safety Considerations with Gastrointestinally Active Lipid-Lowering Drugs
by Jacobson, Terry A., MD
The American journal of cardiology, 2007, Vol.99 (6), p.S47-S55
199.
Effect of Ezetimibe on Major Atherosclerotic Disease Events and All-Cause Mortality
by Hayek, Sami, MD
The American journal of cardiology, 2013, Vol.111 (4), p.532-539
200.
A risk score for predicting mortality in patients with asymptomatic mild to moderate aortic stenosis
by Holme, Ingar
Heart (British Cardiac Society), 2012, Vol.98 (5), p.377-383
